C(OC([N:8]1[CH2:12][CH2:11][CH:10]([O:13][C:14]2[C:15]([F:34])=[CH:16][C:17]3[C:27](=[O:28])[C:26]([C:29]([O:31]CC)=[O:30])=[CH:25][N:19]4[CH:20]([CH3:24])[CH2:21][O:22][C:23]=2[C:18]=34)[CH2:9]1)=O)(C)(C)C.[ClH:35]>C(O)(=O)C>[ClH:35].[NH:8]1[CH2:12][CH2:11][CH:10]([O:13][C:14]2[C:15]([F:34])=[CH:16][C:17]3[C:27](=[O:28])[C:26]([C:29]([OH:31])=[O:30])=[CH:25][N:19]4[CH:20]([CH3:24])[CH2:21][O:22][C:23]=2[C:18]=34)[CH2:9]1Ethyl 10-(1-t-butoxycarbonyl-3-pyrrolidinyloxy)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3de][1,4]-benzoxazine-6-carboxylate (120 mg), 0.6 ml of concentrated hydrochloric acid and 2.6 ml of acetic acid were used. The ester was treated in a similar manner to Example 1-(2) and recrystallized from ethanol, whereby 50 mg of the title compound was obtained.